Rendeiro, André F. http://orcid.org/0000-0001-9362-5373
Ravichandran, Hiranmayi
Bram, Yaron
Chandar, Vasuretha
Kim, Junbum http://orcid.org/0000-0001-7344-1593
Meydan, Cem http://orcid.org/0000-0002-0663-6216
Park, Jiwoon http://orcid.org/0000-0003-0045-1429
Foox, Jonathan
Hether, Tyler
Warren, Sarah
Kim, Youngmi
Reeves, Jason
Salvatore, Steven
Mason, Christopher E. http://orcid.org/0000-0002-1850-1642
Swanson, Eric C. http://orcid.org/0000-0001-8454-1207
Borczuk, Alain C.
Elemento, Olivier
Schwartz, Robert E. http://orcid.org/0000-0002-5417-5995
Article History
Received: 25 October 2020
Accepted: 19 March 2021
First Online: 29 March 2021
Competing interests
: O.E. is scientific advisor and equity holder in Freenome, Owkin, Volastra Therapeutics and OneThree Biotech. R.E.S. is on the scientific advisory board of Miromatrix Inc and is a consultant and speaker for Alnylam Inc. C.E.M. is a cofounder of Biotia and Onegevity Health. E.C.S. is an employee of Fluidigm. T.H., S.W., Y. K. and J.R. are employees of Nanostring Inc. The remaining authors declare no competing financial interests.
Free to read: This content has been made available to all.